Package 25021-234-10

Brand: gemcitabine

Generic: gemcitabine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 25021-234-10
Digits Only 2502123410
Product NDC 25021-234
Product ID 25021-234_595a8cf5-412a-482d-8d77-979741ee4912
Description

1 VIAL in 1 CARTON (25021-234-10) / 5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2014-12-29
Brand gemcitabine
Generic gemcitabine hydrochloride
Sample Package No

Linked Drug Pages (1)

gemcitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "595a8cf5-412a-482d-8d77-979741ee4912", "openfda": {"unii": ["U347PV74IL"], "rxcui": ["1719000", "1719003"], "spl_set_id": ["44bcc16c-341d-49e8-a1c6-95d084667aca"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-234-10)  / 5 mL in 1 VIAL", "package_ndc": "25021-234-10", "marketing_start_date": "20141229"}], "brand_name": "gemcitabine", "product_id": "25021-234_595a8cf5-412a-482d-8d77-979741ee4912", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-234", "generic_name": "gemcitabine hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "gemcitabine", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "200 mg/5mL"}], "application_number": "ANDA202485", "marketing_category": "ANDA", "marketing_start_date": "20141229", "listing_expiration_date": "20261231"}